KRTL BioTech

Devil in the data as funds call for scrutiny of LSE's Refinitiv deal

Devil in the data as funds call for scrutiny of LSE's Refinitiv deal

Some trading and investment firms are calling for competition regulators to scrutinize London Stock Exchange's proposed $27 billion takeover of financial information provider Refinitiv to prevent further market data price hikes.